Sunshine Biopharma, Inc.

SBFM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$5-$5-$27-$12
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$1
Stock-Based Comp.$0$0$0$1
Change in WC-$5-$4$3-$0
Other Non-Cash-$2$0$18$11
Operating Cash Flow-$13-$9-$5-$2
Investing Activities
PP&E Inv.-$2-$0-$0$0
Net Acquisitions$0$0-$14$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$1$0$0
Investing Cash Flow-$2-$1-$15$0
Financing Activities
Debt Repay.$0-$0-$2$3
Stock Issued$9$4$30$0
Stock Repurch.-$3-$1-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$4$0$11$0
Financing Cash Flow$9$3$39$3
Forex Effect-$1$0$0-$0
Net Chg. in Cash-$7-$6$20$1
Supplemental Information
Beg. Cash$16$22$2$1
End Cash$10$16$22$2
Free Cash Flow-$15-$10-$6-$2
Sunshine Biopharma, Inc. (SBFM) Financial Statements & Key Stats | AlphaPilot